Object

This publication is protected and available only for logged users.
This publication is protected and available only for logged users.

Title: Prognostic and predictive significance of HER2 receptorin breast cancer

Abstract:

The aim of trial was assessment of: 1) prognostic value of HER2 receptor and 2) predictive value in adjuvant chemotherapy (CMF vs. anthracycline-containing schedules), and 3) adjuvant hormonal therapy (only with tamoxifen vs. aromatase inhibitors-based therapy), in women with initially operable breast cancer by analyzing the effect of HER2 status assessed with the immunohistochemical method (IHC) on the probability of 5- and 10-year overall and disease-free survival (5y/10yOS and 5y/10yDFS, respectively). The study was performedon group of 391 women operated due to breast cancer from 01.01.1994 in University Hospital in Cracow, and then treated with adjuvant therapy, or observed /follow-up only. The observation of all patients (pts) was completed on the 31.12.2010. The 0, 1+ and 2+ levels of HER2 receptor expression were scored as the normal expression, whereas 3+ level as overexpression. HER2 receptor overexpression was observed in a total of 69 pts (17.6%). It was demonstrated: 1) in one-way ANOVA that HER2 overexpression reduces DFS (HER2 0, 1+, 2+: 5yDFS-78.3%, 10yDFS-60.2% vs. HER2 3+: 5yDFS-62.7%, 10yDFS-31.6%; p<0.001); 2) in two-way ANOVA that progression risk was higher (HR 1.87, 95% CI 1.21-2.90) in pts with overexpression; 3) in the survival analysis that HER2 overexpression in pts treated with tamoxifen only reduced the percentage of 5yOS by ca. 20% (HER2 0, 1+, 2+: 5yOS-90.8% vs. HER2 3+: 5yOS-69.3%; p=0.003), that of 10yOS by ca. 30% (HER2 0, 1+, 2+: 10yOS-84.4% vs. HER2 3+: 10yOS-54.8%; p=0.003), and that of 5y and 10yDFS by ca. 40% (5yDFS-85.1%, 10yDFS-69.4% vs. 5yDFS-47.4%, 10yDFS-31.6%, p<0.001).

Place of publishing:

Kraków

Level of degree:

2 - studia doktoranckie

Degree discipline:

ginekologia ; onkologia

Degree grantor:

Uniwersytet Jagielloński. Collegium Medicum. Wydział Lekarski.

Promoter:

Paweł Basta

Date issued:

2017

Format:

application/pdf

Identifier:

oai:dl.cm-uj.krakow.pl:4193

Call number:

ZB-127018

ControlNumberVIRTUA:

click here to follow the link

Language:

pol

Access rights:

tylko w bibliotece

Location of original object:

Biblioteka Medyczna Uniwersytetu Jagiellońskiego- Collegium Medicum

Object collections:

Last modified:

May 24, 2021

In our library since:

Oct 30, 2017

Number of object content hits:

10

Number of object content views in PDF format

10

All available object's versions:

http://dl.cm-uj.krakow.pl:8080/publication/4194

Show description in RDF format:

RDF

Show description in OAI-PMH format:

OAI-PMH

Edition name Date
ZB-127018 May 24, 2021

Objects

Similar
×

Citation

Citation style:

This page uses 'cookies'. More information